BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Norgine 

Hogehilweg 7
1101 CA
Amsterdam Zuid-Oost      The Netherlands
Phone: 31-20-567-0900 Fax: 31-20-567-0999


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Norgine Release: New Data Show How Hepatic Encephalopathy Contributes To Burden Of Liver Disease 4/11/2014 9:59:24 AM
Altacor Strengthens Commercial Capability With Norgine Collaboration - for the Promotion of Altacor's Dry Eye Product Clinitas® in the UK 7/1/2013 11:01:56 AM
Norgine Release: PBAC Approves XIFAXAN® (Rifaxamin a) 550 mg Cost Effectiveness in Australia 5/28/2013 9:07:39 AM
Tranzyme Pharma (TZYM)/Norgine GI Drug Fails Second Late-stage Trial 5/28/2012 11:17:24 PM
Tranzyme Pharma (TZYM) and Norgine Bowel Drug Fails Trial 3/12/2012 6:58:33 AM
Tranzyme Pharma and Norgine Complete Enrollment in ULISES 008, the Second of Two Phase 3 Pivotal Trials of Ulimorelin 2/28/2012 9:35:14 AM
APR Applied Pharma Research S.A., Labtec GmbH and Norgine Announce the Signature of an Exclusive Licensing Agreement Under Which Norgine will Market and Distribute Setofilmâ„¢ 1/18/2012 6:18:01 AM
Pharma Firm Norgine Plans 36 Job Losses 1/6/2012 8:12:30 AM
Tranzyme Pharma and Norgine Complete Enrollment in First of Two Pivotal Phase 3 Trials of Ulimorelin 12/7/2011 9:50:06 AM
Norgine and Jubilant BioSys Ltd. Announce Discovery Collaboration in Gastrointestinal Therapeutic Area 10/18/2011 6:19:34 AM
12